Cellular retinol-binding protein expression and breast cancer

Journal of the National Cancer Institute

Volumn 92, Issue 6, 2000, Pages 475-480

  Kuppumbatti, Yuvarani S ^a   Bleiweiss, Ira J ^a   Mandeli, John P ^a   Waxman, Samuel ^a   Mira Y Lopez, Rafael ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN;

ARTICLE; BREAST CANCER; CARCINOGENESIS; DISEASE ASSOCIATION; DRUG RECEPTOR BINDING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0034654129     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.6.475     Document Type: Article

References (25)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10: 940-54.
2. Kurlandsky SB, Gamble MV, Ramakrishnan R, Blaner WS. Plasma delivery of retinoic acid to tissues in the rat. J Biol Chem 1995;270: 17850-7.
3. Ong DE, Newcomer ME, Chytil F. Cellular retinoid-binding proteins. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids: biology, chemistry and medicine. New York (NY): Raven Press; 1994. p. 283-317.
4. Napoli J. Retinoic acid biosynthesis and metabolism. FASEB J 1996;10:993-1001.
5. Zelent A. Translocation of the RAR alpha locus to the PML or PLZF gene in acute promyelocytic leukaemia. Br J Haematol 1994;86: 451-60.
6. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, et al. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 1997;57:4992-6.
7. Jing Y, Zhang J, Bleiweiss I, Waxman S, Zelent A, Mira-y-Lopez R. Defective expression of cellular retinol binding protein type I and retinoic acid receptors α2, β2, and γ2 in human breast cancer cells. FASEB J 1996;10: 1064-70.
8. Nilsson MH, Spurr NK, Lundvall J, Rask L, Peterson PA. Human cellular retinol-binding protein gene organization and chromosomal location. Eur J Biochem 1988;173:35-44.
9. Antequera F, Boyes J, Bord A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990;62:503-14.
10. Xu XC, Clifford JL, Hong WK, Lotan R. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diagn Mol Pathol 1994;3:122-31.
11. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. Cancer 1993;72:2979-85.
12. Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-26.
13. Stampfer M, Hallowes RC, Hackett AJ. Growth of normal human mammary cells in culture. In Vitro 1980;16:415-25.
14. Jing Y, Waxman S, Mira-y-Lopez R. The cellular retinoic acid binding protein H is a positive regulator of retinoic acid signaling in breast cancer cells. Cancer Res 1997;57: 1668-72.
15. Pasquali D, Bellastella A, Valente A, Botti G, Capasso I, del Vecchio S, et al. Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer. Eur J Endocrinol 1997;137:410-4.
16. Bavik C, Ward SJ, Ong DE. Identification of a mechanism to localize generation of retinoic acid in rat embryos. Mech Dev 1997;69: 155-67.
17. Ghyselinck NB, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, et al. Cellular retinol-binding protein 1 is essential for vitamin A homeostasis. EMBO J 1999;18:4903-14.
18. Yamamoto M, Drager UC, Ong DE, McCaffery D. Retinoid-binding proteins in the cerebellum and choroid plexus and their relationship to regionalized retinoic acid synthesis and degradation. Eur J Biochem 1998;257:344-50.
19. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996;35: 243-82.
20. Yang Y, Spitzer E, Kenney N, Zschiesche W, Li M, Kromminga A, et al. Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol 1994;127:1097-109.
21. Huynh HT, Larsson C, Narod S, Pollak M. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res 1995;55:2225-31.
22. Davidson NO, Ifkovits CA, Skarosi SF, Hausman AM, Llor X, Sitrin MD, et al. Tissue and cell-specific patterns of expression of rat liver and intestinal fatty acid binding protein during development and in experimental colonic and small intestinal adenocarcinomas. Lab Invest 1993;68:663-75.
23. Smith WC, Nakshatri H, Leroy P, Rees J, Chambon P. A retinoic acid response element is present in the mouse cellular retinol binding protein 1 (mCRBPI) promoter. EMBO J 1991; 10:2223-30.
24. Fisher GJ, Reddy AP, Datta SC, Kang S, Yi JY, Chambon P, et al. All-trans retinoic acid induces cellular retinol-binding protein in human skin in vivo. J Invest Dermatol 1995;105: 80-6.
25. Xu XC, Zile M, Lippman SM, Lee JS, Lee JJ, Hong WK, et al. Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor β expression. Cancer Res 1995;55:5507-11.